Market AdoptionHeartFlow's commercial strategy focuses on increasing adoption, advancing innovation, and expanding clinical leadership, supporting its growth potential.
Reimbursement And CoverageCMS kept HTFL’s plaque reimbursement assigned to New Tech APC 1511, which will reimburse $950.50 starting January 1, 2026, expanding access to plaque scanning and benefiting HeartFlow.
Revenue And GrowthHeartFlow delivered a strong performance in its first public quarter, beating both internal and consensus revenue estimates, and its guidance for FY25 revenue is higher than consensus estimates.